Melucci

1

2

3

4

5

6

7

8 UNITED STATES DISTRICT COURT

9

NORTHERN DISTRICT OF CALIFORNIA

10

SAN JOSE DIVISION

11

12 NICHOLAS MELUCCI, Case No. 19-CV-01372-LHK

13 Plaintiff,

ORDER APPOINTING LEAD

PLAINTIFF AND LEAD COUNSEL

14 v. Re: Dkt. Nos. 15, 17, 24, 29, 32, 58 15 CORCEPT THERAPEUTICS INCORPORATED, et al., 16 Defendants. 17

18 This case is a putative securities class action brought against Defendant Corcept 19 Therapeutics Incorporated (“Corcept”); its President and Chief Executive Officer, Joseph K. 20 Belanoff; and its Chief Financial Officer, Charles Robb. Plaintiffs in this action consist of 21 “persons and entities that purchased or otherwise acquired Corcept securities between August 2, 22 2017 and February 5, 2019, inclusive (the ‘Class Period’).” ECF No. 1 (“Compl.”) ¶ 1. Before 23 the Court are four outstanding Motions for Appointment as Lead Plaintiff and Approval of Lead 24 Counsel. 25 I. BACKGROUND 26 Corcept is a “pharmaceutical company that purports to develop medications to treat severe 27 metabolic, oncologic, and psychiatric disorders by modulating the…